Functional capacity of macrophages determines the induction of type 1 diabetes

Annals of the New York Academy of Sciences

Volumn 1084, Issue , 2006, Pages 49-57

  Mensah Brown, E P K ^a   Shahin, A ^a   Parekh, Khatija ^a   Al Hakim, A ^a   Al Shamisi, M ^a   Hsu, D K ^b   Lukic, M L ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmunity; Galectin 3; Multiple low dose streptozotocin; ST2

Indexed keywords

GALAPTIN; GALECTIN 3; INSULIN; INTERLEUKIN 1 RECEPTOR LIKE PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENE DELETION; HISTOPATHOLOGY; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; STATISTICAL SIGNIFICANCE; TH1 CELL; ANIMAL; ARTICLE; EXPERIMENTAL DIABETES MELLITUS; GENETICS; HUMAN; IMMUNOLOGY; MOUSE MUTANT; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY; TH2 CELL;

MUS;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; GALECTIN 3; HUMANS; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; TH2 CELLS;

EID: 34447633187     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1372.014     Document Type: Conference Paper

References (27)

1. KOLB, H., V. BURKART, B. APPELS, et al. 1990. Essential contribution of macrophages to islet cell destruction in vivo and in vitro. J. Autoimmun. Suppl 1:117-120.
2. LUKIC, M.L., S. STOSIC-GRUJICIC & A. SHAHIN. 1998. Effector mechanisms in low-dose streptozotocin-induced diabetes. Dev. Immunol. 6: 119-128.
3. HOMO-DELARCHE, F. & H.A. DREXHAGE. 2004. Immune cells, pancreas development, regeneration and type 1 diabetes. Trends Immunol. 25: 222-229.
4. HSU, D.K., R.Y. YANG, Z. PAN, et al. 1994. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am. J. Pathol. 156: 1073-1083.
5. TRAJKOVIC, V., M. SWEET & X. DAMO. 2004. T1/ST2 - an IL-1 receptor-like modulator of immune responses. Cytokine Growth Factor Rev. 15: 87-95.
6. LIU, F.T., D.K. HSU, R.I. ZUBERI, et al. 1995. Expression and function of galectin-3, a beta galactoside-binding lectin, in human monocytes and macrophages. Am. J. Pathol. 147: 1016-1028.
7. DUMIC, J., S. DABELIC & M. FLÖGEL. 2006. Galectin-3: an open story. Biochim. Biophys. Acta 1760: 616-635.
8. JENG, K.C., L.G. FRIGERI & F.T. LIU. 1994. An endogenous lectin, galectin-3(epsilon BP/Mac-2) potentiates IL-1 production by human monocytes. Immunol. Lett. 42: 113-116.
9. SANO, H., D.K. HSU, L. YU, et al. 2000. Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J. Immunol. 165: 2156-2164.
10. SANO, H., D.K. HSU, J.R. APGAR, et al. 2003. Critical role of galectin-3 in phagocytosis by macrophages. J. Clin. Invest. 112: 389-397.
11. SATO, S. & J. NIEMINEM. 2004. Seeing strangers or announcing "danger" galectin-3 in two models of innate immunity. Glycoconj. J. 19: 583-591.
12. OSHIMA, S., S. KUCHEN & C.A. SEEMAYER, et al. 2003. Galectin-3 and its binding protein in rheumatoid arthritis. Arthritis Rheum. 48: 2788-2795.
13. SWEET, M.J., B.P. LEUNG, D. KANG, et al. 2001. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of toll-like receptor 4 expression. J. Immunol. 166: 6633-6639.
14. GRITZMACHER, C.A., V.S. MEHL & F.T. LIU. 1992. Genomic cloning of the gene for an IgE binding lectin reveals unusual utilization of 5′ untranslated regions. Biochemistry 31: 9533-9538.
15. TOWNSEND, M.J., P.G. FALLON, D.J. MATTHEWS, et al. 2000. T1/ST2 -deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell 2 responses. J. Exp. Med. 191: 9069-9076.
16. MENSAH-BROWN, E.P.K., A. SHAHIN, M. AL SHAMSI, et al. 2006. IL-23 leads to diabetes induction after subdiabetogenic treatment with multiple doses of streptozotocin. Eur. J. Immunol. 26: 216-223.
17. MUELLER, R., M. LEE. S.P. SAWYER, et al. 1996. Transgenic expression of interleukin 10 in the pancreas renders resistant mice susceptible to low dose streptozotocin-induced diabetes. J. Autoimmunity 9: 151-158.
18. BETTELLI, E. & V.K. KUCHROO. 2005. IL-12 and IL-23-induced T helper cell subsets: birds of the same feather flock together. J. Exp. Med. 201: 169-171.
19. JANSEN, A., F. HOMO-DELARCHE, H. HOOIJKAAS, et al. 1994. Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta cell destruction in NOD mice. Diabetes 43: 667-675.
20. COLNOT, C., M.A. RIPOCHE, G. MILON, et al. 1998. Maintenance of granulocyte numbers during acute peritonitis is defective in galectin-3-null mutant mice. Immunology 94: 290-296.
21. SWARTE, V.V., R.E. MEBIUS, D.H. JOZIASSE, et al. 1998. Lymphocyte triggering via L-selectin leads to enhanced galectin-3 mediated binding to dendritic cells. Eur. J. Immunol. 28: 2846-2871.
22. YAMAKO, A., I. KUWABARA, L.G. FRIGERI, et al. 1995. A human lectin, galectin-3 (epsilon bp/Mac-2) stimulates superoxide production by neutrophils. J. Immunol. 154: 3479-3487.
23. KRÖNCKE, K., V. KOLB-BACHOFEN, B. BERSCHICK, et al. 1991. Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation. Biochem. Biophys. Res. Commun. 175: 752-758.
24. LUKIC, M.L., S. STOSIC-GRUJICIC, N. OSTOJIC, et al. 1991. Inhibition of nitric oxide generation affects the induction of diabetes by streptozotocin in mice. Biochem. Biophys. Res. Commun. 178: 913-920.
25. MOSSMAN, T.R. & S. SAD. 1996. The expanding universe of T-cell subsets: Th1, Th2, and more. Immunol. Today 17: 138-146.
26. TRAJKOVIC, V., M.J. SWEET & D. XU. 2004. T1/ST2 -an IL-1 receptor modulator of immune responses. Cytokines Growth Factors Rev. 15: 87-95.
27. LEUNG, B.P., D. XU, S. CULSHAW, et al. 2004. A novel therapy of murine collagen-induced arthritis with soluble T1/ST2. J. Immunol. 173: 145-150.